Joan Merrill to Thrombosis
This is a "connection" page, showing publications Joan Merrill has written about Thrombosis.
Connection Strength
1.333
-
Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications. Nat Rev Rheumatol. 2020 10; 16(10):581-589.
Score: 0.606
-
Dual antibody reactivity to beta2-glycoprotein I and protein S: increased association with thrombotic events in the antiphospholipid syndrome. Lupus. 2002; 11(4):215-20.
Score: 0.167
-
Which antiphospholipid antibody tests are most useful? Rheum Dis Clin North Am. 2001 Aug; 27(3):525-49.
Score: 0.162
-
Enhancement of protein S anticoagulant function by beta2-glycoprotein I, a major target antigen of antiphospholipid antibodies: beta2-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4b-binding protein. Thromb Haemost. 1999 May; 81(5):748-57.
Score: 0.139
-
Catastrophic antiphospholipid syndrome. Nat Clin Pract Rheumatol. 2006 Feb; 2(2):81-9.
Score: 0.056
-
Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome. Am J Clin Pathol. 2004 Jan; 121(1):142-9.
Score: 0.048
-
IgG autoantibodies against beta2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome. Clin Dev Immunol. 2003 Jun-Dec; 10(2-4):203-11.
Score: 0.046
-
What causes the antiphospholipid syndrome? Curr Rheumatol Rep. 2001 Aug; 3(4):293-300.
Score: 0.041
-
High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. Arthritis Rheum. 2001 Jun; 44(6):1466-7.
Score: 0.040
-
Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment. Semin Thromb Hemost. 2008 Apr; 34(3):256-66.
Score: 0.016
-
Antibodies directed to protein S in patients with systemic lupus erythematosus: prevalence and clinical significance. Thromb Haemost. 2003 Oct; 90(4):636-41.
Score: 0.012